A US clinical research company has announced a multi-million pound investment in its Livingston campus, creating 156 new jobs.
Q2 Solutions has received a Scottish Enterprise grant of £ 3.8million to help create a new ‘center of excellence’ for flow cytometry and genomics testing and analysis.
The investment will create new skilled jobs over the next three years, allowing the company to offer an expanded range of services to its clients, which include a range of pharmaceutical companies.
The multi-million pound research and development project will help anchor Q2 Solutions’ operations in Scotland.
The new project will coincide with its ongoing £ 17million infrastructure expansion project on campus, where the company already employs more than 950 people.
Economic Secretary Kate Forbes said: “Foreign investment has a huge role to play in Scotland’s economic transformation – our skilled workforce, our research facilities and our investment culture. favorable are very attractive to foreign companies. “
Elaine Lowey, Managing Director of Q2 Solutions for Europe, Middle East & Africa, said: “Expanding our European operations into key technical areas supporting the development of new precision medicines adds significant value. to our global pharmaceutical and biotechnology customers.
“We are delighted to be working with Scottish Enterprise on this venture and look forward to the job creation this will bring to our new, state-of-the-art facility. “
Don’t miss the latest headlines with our twice daily newsletter – subscribe here for free.